Mary E. Moreno

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection <i>in vitro</i> and <i>in vivo</i>

Julie Strizki, Serena Xu, Nicole Wagner et al. · Proceedings of the National Academy of Sciences · 2001 · 300 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery et al. · Nature Biotechnology · 2020 · 299 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Test performance evaluation of SARS-CoV-2 serological assays

Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery et al. · medRxiv · 2020 · 253 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice

Dirk P. Dittmer, Cheryl A. Stoddart, Rolf Renne et al. · The Journal of Experimental Medicine · 1999 · 111 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

CCR5- and CXCR4-Utilizing Strains of Human Immunodeficiency Virus Type 1 Exhibit Differential Tropism and Pathogenesis In Vivo

Robert D. Berkowitz, Sabina A. Alexander, Valerie Linquist-Stepps et al. · Journal of Virology · 1998 · 104 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14